Regeneron Pharmaceuticals, Inc.

Last update: Mar 25, 2026 at 04:53

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company operates across multiple therapeutic areas, with flagship products including Eylea and Eylea HD for eye diseases such as wet age-related macular degeneration and diabetic macular edema; Dupixent for atopic dermatitis, asthma, and allergic conditions; Libtayo for cutaneous squamous cell carcinoma and other cancers; and Kevzara for rheumatoid arthritis. Regeneron also develops monoclonal and bispecific antibodies through collaborations with partners like Sanofi, and maintains early-stage partnerships in gene editing and RNA interference technologies. The company employs proprietary VelociSuite technologies, including VelocImmune, to accelerate drug development by utilizing genetically humanized mice to produce optimized fully human antibodies. Founded in 1988 and headquartered in Tarrytown, New York, Regeneron serves patients across oncology, immunology, ophthalmology, and cardiovascular disease markets globally.

Dividend Overview

Dividend Yield

0.47%

Annual Dividend

$3.58

Frequency

Quarterly

Payout Ratio

8.49%

FCF Payout Ratio

9.83%

Stock Price

$741.69

52-Week Range

$476.49 – $821.11

Dividend Health Score

Very Safe

Dividend Health Assessment

REGN's dividend appears very safe. Strengths include a 8.5% earnings payout ratio & 9.8% fcf payout ratio. Areas of concern: 1+ yrs dividend streak & 0.0% 5-year dividend cagr.

Based on 14 of 15 metrics

Payout & Coverage

Very Safe

Earnings Payout Ratio

8.5%Very Safe

FCF Payout Ratio

9.8%Very Safe

CFO Payout Ratio

5.9%Very Safe

Interest Coverage

120.4xVery Safe

Balance Sheet

Very Safe

Net Debt / Total Assets

N/AN/A

Current Ratio

4.1xVery Safe

Debt-to-Equity

9.5Very Safe

Profitability

Safe

Return on Equity

14.9%Safe

Operating Margin

23.1%Safe

Gross Margin

85.0%Very Safe

Profit Margin Stability

StableSafe

Dividend Track Record

Caution

1+ yrsDanger

NoneVery Safe

0.0%Warning

GrowingVery Safe

Dividend History (2016–2025)

REGN annual dividend per share and yield history

Earnings & Profitability

REGN earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

February 20, 2026

Next Payment Date

March 5, 2026

Dividend Growth

3-Year Dividend CAGR

0.00%

5-Year Dividend CAGR

0.00%

10-Year Dividend CAGR

0.00%

3-Year Total Growth

0.00%

5-Year Total Growth

0.00%

10-Year Total Growth

0.00%

Income Calculator

REGN Dividend Calculator

Number of Shares

Total Investment

$74,169.00

Annual Income

$358.00

Quarterly Income

$89.50

Monthly Income

$29.83

Similar Dividend Stocks

Stock	Yield	5Y CAGR	Price	Sector
REGN	0.47%	0.00%	$741.69	Healthcare
CIThe Cigna Group	2.27%	172.77%	$265.87	Healthcare
CORCencora Inc.	0.66%	-15.97%	$327.27	Healthcare
ELVElevance Health, Inc.	2.35%	12.47%	$290.33	Healthcare
IDXXIDEXX Laboratories, Inc.	0.00%	N/A	$570.21	Healthcare
INCYIncyte Corporation	0.00%	N/A	$90.62	Healthcare
ZTSZoetis Inc.	1.72%	20.11%	$115.93	Healthcare

Frequently Asked Questions

What is REGN's current dividend yield?

Regeneron Pharmaceuticals, Inc. (REGN) currently has a dividend yield of 0.47%, based on a stock price of $741.69 and an annual dividend of $3.58.

When is REGN's next dividend payment date?

REGN's next ex-dividend date is 2026-02-20 and the next payment date is 2026-03-05. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does REGN pay in dividends per year?

Regeneron Pharmaceuticals, Inc. paid $3.52 per share in annual dividends in 2025. The dividends are paid quarterly.

Has REGN been increasing its dividend?

Regeneron Pharmaceuticals, Inc. has grown its dividend at a 5-year CAGR of 0.00% and a 10-year CAGR of 0.00%.

Is REGN's dividend safe?

Regeneron Pharmaceuticals, Inc. has a payout ratio of 8.49%. Its free cash flow payout ratio is 9.83%. A payout ratio below 60% is generally considered sustainable.

How is REGN's Dividend Health Score calculated?

The Dividend Health Score evaluates Regeneron Pharmaceuticals, Inc.'s dividend sustainability across four categories: Payout & Coverage (40%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (20%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track REGN Dividends with OnlyDividends

What will REGN actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.